Heart transplantation

A single-center experience

Miralem Pasic, Matthias Loebe, Manfred Hummel, Onen Grauhan, Josef Hofmeister, Yuguo Weng, Roland Hetzer

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background. The success of heart transplantation led to the extension of the criteria for both recipients and donors. The aim of the study was to evaluate the experience with this therapeutic approach for end-stage heart failure at a single center. Methods. Between April 1986 and January 1996, 1,413 patients were accepted as candidates for heart transplantation. Ventricular assist devices were used as a bridge to transplantation in 173 patients (biventricular assist device in 141 patients and left ventricular assist device in 32 patients). The longest duration of support was 572 days (average, 46 days). Results. Of the 1,413 patients, 891 underwent heart transplantation (65 children/adolescents and 826 adults); 522 (36%) patients died awaiting a donor heart. The average time spent on the waiting list was 107 days. The average recipient age was 44 years, and the age of donors was extended up to 69 years. Eighty-three patients with ventricular assist devices (48%) subsequently underwent heart transplantation. Twenty-five patients (2.7%) underwent retransplantation. The 30-day mortality rate was 14%, and the overall actual survival at 1, 5, and 10 years was 80%, 59%, and 50%, respectively. Ninety-four percent of patients were in New York Heart Association functional class I or II at 1 year, and 44% returned to work after transplantation. Conclusions. Despite the broadening of the selection criteria for both recipients and donors, heart transplantation remains an effective treatment for end-stage heart failure. Nevertheless, this therapeutic approach is severely limited by a considerable disparity between the need and availability of donor organs.

Original languageEnglish (US)
Pages (from-to)1685-1690
Number of pages6
JournalAnnals of Thoracic Surgery
Volume62
Issue number6
DOIs
StatePublished - Dec 1996
Externally publishedYes

Fingerprint

Heart Transplantation
Tissue Donors
Heart-Assist Devices
Heart Failure
Transplantation
Waiting Lists
Patient Selection
Therapeutics
Equipment and Supplies
Survival
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Pasic, M., Loebe, M., Hummel, M., Grauhan, O., Hofmeister, J., Weng, Y., & Hetzer, R. (1996). Heart transplantation: A single-center experience. Annals of Thoracic Surgery, 62(6), 1685-1690. https://doi.org/10.1016/S0003-4975(96)00815-6

Heart transplantation : A single-center experience. / Pasic, Miralem; Loebe, Matthias; Hummel, Manfred; Grauhan, Onen; Hofmeister, Josef; Weng, Yuguo; Hetzer, Roland.

In: Annals of Thoracic Surgery, Vol. 62, No. 6, 12.1996, p. 1685-1690.

Research output: Contribution to journalArticle

Pasic, M, Loebe, M, Hummel, M, Grauhan, O, Hofmeister, J, Weng, Y & Hetzer, R 1996, 'Heart transplantation: A single-center experience', Annals of Thoracic Surgery, vol. 62, no. 6, pp. 1685-1690. https://doi.org/10.1016/S0003-4975(96)00815-6
Pasic M, Loebe M, Hummel M, Grauhan O, Hofmeister J, Weng Y et al. Heart transplantation: A single-center experience. Annals of Thoracic Surgery. 1996 Dec;62(6):1685-1690. https://doi.org/10.1016/S0003-4975(96)00815-6
Pasic, Miralem ; Loebe, Matthias ; Hummel, Manfred ; Grauhan, Onen ; Hofmeister, Josef ; Weng, Yuguo ; Hetzer, Roland. / Heart transplantation : A single-center experience. In: Annals of Thoracic Surgery. 1996 ; Vol. 62, No. 6. pp. 1685-1690.
@article{fdd28867f31b447182d472d399f6c0eb,
title = "Heart transplantation: A single-center experience",
abstract = "Background. The success of heart transplantation led to the extension of the criteria for both recipients and donors. The aim of the study was to evaluate the experience with this therapeutic approach for end-stage heart failure at a single center. Methods. Between April 1986 and January 1996, 1,413 patients were accepted as candidates for heart transplantation. Ventricular assist devices were used as a bridge to transplantation in 173 patients (biventricular assist device in 141 patients and left ventricular assist device in 32 patients). The longest duration of support was 572 days (average, 46 days). Results. Of the 1,413 patients, 891 underwent heart transplantation (65 children/adolescents and 826 adults); 522 (36{\%}) patients died awaiting a donor heart. The average time spent on the waiting list was 107 days. The average recipient age was 44 years, and the age of donors was extended up to 69 years. Eighty-three patients with ventricular assist devices (48{\%}) subsequently underwent heart transplantation. Twenty-five patients (2.7{\%}) underwent retransplantation. The 30-day mortality rate was 14{\%}, and the overall actual survival at 1, 5, and 10 years was 80{\%}, 59{\%}, and 50{\%}, respectively. Ninety-four percent of patients were in New York Heart Association functional class I or II at 1 year, and 44{\%} returned to work after transplantation. Conclusions. Despite the broadening of the selection criteria for both recipients and donors, heart transplantation remains an effective treatment for end-stage heart failure. Nevertheless, this therapeutic approach is severely limited by a considerable disparity between the need and availability of donor organs.",
author = "Miralem Pasic and Matthias Loebe and Manfred Hummel and Onen Grauhan and Josef Hofmeister and Yuguo Weng and Roland Hetzer",
year = "1996",
month = "12",
doi = "10.1016/S0003-4975(96)00815-6",
language = "English (US)",
volume = "62",
pages = "1685--1690",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Heart transplantation

T2 - A single-center experience

AU - Pasic, Miralem

AU - Loebe, Matthias

AU - Hummel, Manfred

AU - Grauhan, Onen

AU - Hofmeister, Josef

AU - Weng, Yuguo

AU - Hetzer, Roland

PY - 1996/12

Y1 - 1996/12

N2 - Background. The success of heart transplantation led to the extension of the criteria for both recipients and donors. The aim of the study was to evaluate the experience with this therapeutic approach for end-stage heart failure at a single center. Methods. Between April 1986 and January 1996, 1,413 patients were accepted as candidates for heart transplantation. Ventricular assist devices were used as a bridge to transplantation in 173 patients (biventricular assist device in 141 patients and left ventricular assist device in 32 patients). The longest duration of support was 572 days (average, 46 days). Results. Of the 1,413 patients, 891 underwent heart transplantation (65 children/adolescents and 826 adults); 522 (36%) patients died awaiting a donor heart. The average time spent on the waiting list was 107 days. The average recipient age was 44 years, and the age of donors was extended up to 69 years. Eighty-three patients with ventricular assist devices (48%) subsequently underwent heart transplantation. Twenty-five patients (2.7%) underwent retransplantation. The 30-day mortality rate was 14%, and the overall actual survival at 1, 5, and 10 years was 80%, 59%, and 50%, respectively. Ninety-four percent of patients were in New York Heart Association functional class I or II at 1 year, and 44% returned to work after transplantation. Conclusions. Despite the broadening of the selection criteria for both recipients and donors, heart transplantation remains an effective treatment for end-stage heart failure. Nevertheless, this therapeutic approach is severely limited by a considerable disparity between the need and availability of donor organs.

AB - Background. The success of heart transplantation led to the extension of the criteria for both recipients and donors. The aim of the study was to evaluate the experience with this therapeutic approach for end-stage heart failure at a single center. Methods. Between April 1986 and January 1996, 1,413 patients were accepted as candidates for heart transplantation. Ventricular assist devices were used as a bridge to transplantation in 173 patients (biventricular assist device in 141 patients and left ventricular assist device in 32 patients). The longest duration of support was 572 days (average, 46 days). Results. Of the 1,413 patients, 891 underwent heart transplantation (65 children/adolescents and 826 adults); 522 (36%) patients died awaiting a donor heart. The average time spent on the waiting list was 107 days. The average recipient age was 44 years, and the age of donors was extended up to 69 years. Eighty-three patients with ventricular assist devices (48%) subsequently underwent heart transplantation. Twenty-five patients (2.7%) underwent retransplantation. The 30-day mortality rate was 14%, and the overall actual survival at 1, 5, and 10 years was 80%, 59%, and 50%, respectively. Ninety-four percent of patients were in New York Heart Association functional class I or II at 1 year, and 44% returned to work after transplantation. Conclusions. Despite the broadening of the selection criteria for both recipients and donors, heart transplantation remains an effective treatment for end-stage heart failure. Nevertheless, this therapeutic approach is severely limited by a considerable disparity between the need and availability of donor organs.

UR - http://www.scopus.com/inward/record.url?scp=0030540955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030540955&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(96)00815-6

DO - 10.1016/S0003-4975(96)00815-6

M3 - Article

VL - 62

SP - 1685

EP - 1690

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -